In:  Announcements  
RExPO22 – connecting the dots on drug repurposing

RExPO22 – connecting the dots on drug repurposing

REPO4EU is a Horizon Europe project that aims to create a connected European Platform for Drug Repurposing that will integrate the scientific, methodological, financial, legal, regulatory, and IP dimensions of drug repurposing, as well as enable and facilitate seamless access to, pooling, and sharing of high-quality data assets in the field.

The 1st International Conference on Drug Repurposing will kick off this project, and it will surely be an event not to be missed.

RExPO22, the first in the RExPO yearly conference series, will be held in Maastricht, the Netherlands, from September 2nd to 3rd, 2022.

Professional societies, companies, patent attorneys, legal and ethics experts, clinical research groups, regulators, payers, patient representatives, and many others have already joined REPO4EU and RExPO22, and the conference will be a great opportunity to contribute to the creation and strengthening of global alliances that pool their knowledge and know-how to produce the best possible outcome in drug repurposing.

ScienceOpen will be proudly hosting the conference proceedings and is glad to be part of such an interesting and inspiring community.

In our unique collection infrastructure, ScienceOpen allows open access to publishing for conference papers. This gives conferences an online presence and increases dissemination and awareness of conference proceedings through integration into ScienceOpen’s discovery environment.

Key topics of RExPO22

The conference will bring together world-renown researchers and scholars, practitioners, and specialists from the field. Networking has always been the prime focus of any scientific and business event and this one is both: high impact science and innovative business.

Key Speakers on the Conference.

The key topics of the first International Conference on Drug Repurposing will include:

  • Redefining disease
  • Organ-agnostic medicine
  • Network pharmacology
  • Artificial Intelligence to serve drug repurposing
  • The regulatory, ethical and safety perspectives
  • Rethinking pharma – from lab to market
  • 2D and 3D-printed drugs and drug reformulation
  • The road to precision medicine
  • Clinical trials: strategy and management

Interested in joining?

Submit an abstract to the RExPO22 Conference!

This is a once-in-a-lifetime opportunity to gain international exposure for your work and connect the dots on drug repurposing. For more details, have a look at the conference collection page or RExPO22 Conference visit RExPO22’s official website: RExPO22 – The 1st International Conference on Drug Repurposing – REPO4EU

And if you want to highlight your conference’s material, and put them in the context of 78+ million scholarly publications, you can get in touch with us anytime.

Leave a Reply

Your email address will not be published.